Key result
MALT and non-MALT primary pulmonary lymphoma demonstrated estimated 5-year overall survival rates of 68.9% and 65.9%, respectively, with age >60 years acting as an independent prognostic factor (P=0.013).
Why the study?
Primary pulmonary lymphoma is rare, and due to limited sample sizes in prior studies, clinical data and understanding of the disease remain inadequate.
What are the clinicopathological characteristics and prognostic factors for overall survival in patients with primary pulmonary lymphoma?
Cohort (n=90)
No
What are the clinicopathological characteristics and prognostic factors for overall survival in patients with primary pulmonary lymphoma?
Absolute Event Rate: 68.9% vs 65.9%
Age over 60 years, elevated LDH and β2-MG levels, advanced clinical stage, and nonsurgical treatment are associated with poor prognosis in patients with primary pulmonary lymphoma.
No takes yet. Share an insight, caveat, or question.
Similar survival in MALT and non-MALT pulmonary lymphoma should not yet change practice; leaves open validation of age as prognostic factor.
He et al. (2021) conducted a cohort in Primary pulmonary lymphoma (n=90). MALT lymphoma vs. non-MALT lymphoma was evaluated on 5-year overall survival. MALT and non-MALT primary pulmonary lymphoma demonstrated estimated 5-year overall survival rates of 68.9% and 65.9%, respectively, with age >60 years acting as an independent prognostic factor (P=0.013).
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: